{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:54:52Z","timestamp":1776426892355,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prevalence of non-motor symptoms (NMS) in Parkinson\u2019s Disease (PD) has varied between studies. Their interrelation isn\u2019t totally understood. Also, the relative importance of each symptom, regarding its impact on activities of daily living (ADL) and health related quality of life (HRQL), remains debatable. We assessed all PD patients attending a Portuguese tertiary movement disorders center during one year (n\u2009=\u2009134), with ADL, HRQL and other clinical scales approved for identifying the most relevant NMS in PD. All patients had at least one NMS. Sleep\/fatigue, affect\/cognition, attention\/memory were the most frequent complaints and their prevalence, above 80%, was higher than in most studies. There were significantly correlations between: sleepiness, psychosis and cognition; gastrointestinal, cardiovascular symptoms and pain; depression and apathy; anxiety and insomnia; olfaction, weight and hyperhidrosis. Depression\/apathy exerted the strongest influence on HRQL and non-tremor motor dysfunction on ADL. Compared to studies in other countries, we found a higher prevalence of NMS, which could be specific of this population. The interrelation between NMS could be related to degeneration of different brain structures. NMS exert a stronger influence than MS in HRQL, which should be taken in account regarding treatment options.<\/jats:p>","DOI":"10.1038\/srep32267","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T09:39:21Z","timestamp":1472549961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Non-Motor symptoms in Portuguese Parkinson\u2019s Disease patients: correlation and impact on Quality of Life and Activities of Daily Living"],"prefix":"10.1038","volume":"6","author":[{"given":"Paulo","family":"Bugalho","sequence":"first","affiliation":[]},{"given":"T\u00e2nia","family":"Lampreia","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Miguel","sequence":"additional","affiliation":[]},{"given":"Marcelo D.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Caetano","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Barbosa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"BFsrep32267_CR1","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/mds.23394","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher, D. A., Lees, A. J. & Schrag, A. What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them? Mov. Disord. 25, 2493\u20132500 (2010).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/ene.12733","volume":"22","author":"P Zis","year":"2015","unstructured":"Zis, P. et al. Non-motor symptoms burden in treated and untreated early Parkinson\u2019s disease patients: argument for non-motor subtypes. Eur. J. Neurol. 22(8), 1145\u20131150 (2015).","journal-title":"Eur. J. Neurol."},{"key":"BFsrep32267_CR3","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri, K. R. et al. The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study. Mov. Disord. 22, 1901\u20131911 (2007).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.clineuro.2012.07.032","volume":"115","author":"EM Khedr","year":"2013","unstructured":"Khedr E. M. et al. Prevalence of non motor features in a cohort of Parkinson\u2019s disease patients. Clinical Neurol. Neurosurg. 115(6), 673\u2013677 (2013).","journal-title":"Clinical Neurol. Neurosurg."},{"key":"BFsrep32267_CR5","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/mds.23368","volume":"25","author":"H Li","year":"2010","unstructured":"Li H. et al. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson\u2019s disease. Mov. Disord. 25(16), 2740\u20132746 (2010).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR6","first-page":"912037","volume":"2013","author":"P Bugalho","year":"2013","unstructured":"Bugalho, P. & Viana-Baptista, M. Predictors of cognitive decline in the early stages of Parkinson\u2019s disease: a brief cognitive assessment longitudinal study. Parkinsons Dis. 2013, 912037 (2013).","journal-title":"Parkinsons Dis."},{"key":"BFsrep32267_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00415-011-6140-8","volume":"259","author":"P Bugalho","year":"2012","unstructured":"Bugalho, P. et al. Psychiatric symptoms screening in the early stages of Parkinson\u2019s disease. J. Neurol. 259(1), 124\u2013131 (2012).","journal-title":"J. Neurol."},{"key":"BFsrep32267_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/mds.20719","volume":"21","author":"E Sinforiani","year":"2006","unstructured":"Sinforiani, E. et al. REM Sleep Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson\u2019s Disease. Mov. Disord. 21(4), 462\u2013466 (2006).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1212\/WNL.55.2.281","volume":"55","author":"I Arnulf","year":"2000","unstructured":"Arnulf, I. et al. Hallucinations, REM sleep and Parkinson\u2019s disease: a medical hypothesis. Neurology 55(2), 281\u2013288 (2000).","journal-title":"Neurology"},{"key":"BFsrep32267_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"SE Starkstein","year":"1992","unstructured":"Starkstein S. E. et al. Reliability, validity and clinical correlates of apathy in Parkinson\u2019s disease. J. Neuropsychiatry Clin. Neurosci. 4, 134\u2013139 (1992).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"BFsrep32267_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P. et al. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov. Disord. 26, 399\u2013406 (2011).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mds.25664","volume":"29","author":"GW Duncan","year":"2014","unstructured":"Duncan G. W. et al. Health related quality of life in early Parkinson\u2019s disease: The impact of non-motor symptoms. Mov. Disord. 29(2), 195\u2013202 (2014).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00415-008-0994-4","volume":"255","author":"M Visser","year":"2008","unstructured":"Visser M. et al. A comprehensive model of health related quality of life in Parkinson\u2019s disease. J. Neurol. 255, 1580\u20131587 (2008).","journal-title":"J. Neurol."},{"key":"BFsrep32267_CR14","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","volume":"70","author":"D Muslimovic","year":"2008","unstructured":"Muslimovic D. et al. Determinants of disability and quality of life in mild to moderate Parkinson\u2019s disease. Neurology 70, 2241\u20132247 (2008).","journal-title":"Neurology"},{"key":"BFsrep32267_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P. et al. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov. Disord. 26, 399\u2013406 (2011).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11136-010-9785-3","volume":"20","author":"LN Ferreira","year":"2011","unstructured":"Ferreira L. N. et al. Do Portuguese and UK health state values differ across valuation methods? Qual Life Res. 20(4), 609\u2013619 (2011).","journal-title":"Qual Life Res."},{"key":"BFsrep32267_CR17","unstructured":"OECD. OECD Development Co-operation Peer Reviews: Portugal 2016, OECD Development Co-operation Peer Reviews, OECD Publishing, Paris, (2015)."},{"key":"BFsrep32267_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.sleep.2004.10.006","volume":"6","author":"CR Soldatos","year":"2005","unstructured":"Soldatos C. R. et al. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Med. 6(1), 5\u201313 (2005).","journal-title":"Sleep Med."},{"key":"BFsrep32267_CR19","unstructured":"Almeida J. et al. Estudo Epidemiol\u00f3gico Nacional de Sa\u00fade Mental, 1\u00b0 relat\u00f3rio. World Mental Health Surveys Initiative: Lisboa (2013)."},{"key":"BFsrep32267_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.parkreldis.2013.05.006","volume":"19","author":"JG Goldman","year":"2013","unstructured":"Goldman J. G. et al. Dissociations among daytime sleepiness, nighttime sleep and cognitive status in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 19, 806\u2013811 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFsrep32267_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.parkreldis.2012.11.009","volume":"19","author":"A Fil","year":"2013","unstructured":"Fil A. et al. Pain in Parkinson disease: A review of the literature. Parkinsonism Relat. Disord. 19, 285\u2013294 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFsrep32267_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mds.22760","volume":"25","author":"L N\u00e8gre-Pag\u00e8s","year":"2010","unstructured":"N\u00e8gre-Pag\u00e8s L. et al. Anxious and depressive symptoms in Parkinson\u2019s disease: the French cross-sectionnal DoPAMiP study. Mov. Disord. 25(2), 157\u2013166 (2010).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.parkreldis.2015.09.025","volume":"21","author":"P Ratti","year":"2015","unstructured":"Ratti P., N\u00e8gre-Pag\u00e8s L. & P\u00e9rez-Lloret S. Subjective sleep dysfunction and insomnia symptoms in Parkinson\u2019s disease: Insights from a cross-sectional evaluation of the French CoPark cohort. Parkinsonism Relat. Disord. 21(11), 1323\u20131329 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFsrep32267_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.parkreldis.2012.05.004","volume":"18","author":"JC Sharma","year":"2012","unstructured":"Sharma J. C. & Turton J. Olfaction, dyskinesia and profile of weight change in Parkinson\u2019s disease: identifying neurodegenerative phenotypes. Parkinsonism Relat. Disord. 18, 964\u2013970 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFsrep32267_CR25","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1212\/WNL.43.11.2227","volume":"43","author":"CG Goetz","year":"1993","unstructured":"Goetz C. G. & Stebbins G. T. Risk factors for nursing home placement in advanced Parkinson\u2019s disease. Neurology 43(11), 2227\u20132229 (1993).","journal-title":"Neurology"},{"key":"BFsrep32267_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes A. J., Daniel S. E., Kilford L. & Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55(3), 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFsrep32267_CR27","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25(15), 2649\u20132685 (2010).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn M. M. & Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"BFsrep32267_CR29","unstructured":"Fahn, S. et al. Unified Parkinson\u2019s Disease Rating Scale (UPDRS) In Recent developments In Parkinson\u2019s Disease (eds Fahn S, Marsden CD, Goldstein M & Calne DB ), 153\u2013163 (McMillan Health Care, 1987)."},{"key":"BFsrep32267_CR30","unstructured":"Schwab, J. F. & England, A. C. Projection technique for evaluating surgery in Parkinson\u2019s disease. In Gillingham, F. J., Donaldson, M. C. editors, Third Symposium on Parkinson\u2019s Disease Edinburgh, E & S Livingstone, 1969)."},{"key":"BFsrep32267_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"Group EuroQol","year":"1990","unstructured":"EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 16, 199\u2013208 (1990).","journal-title":"Health Policy."},{"key":"BFsrep32267_CR32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.20344\/amp.1317","volume":"26","author":"PL Ferreira","year":"2013","unstructured":"Ferreira, P. L., Ferreira, L. N. & Pereira, L. N. [Contribution for the validation of the Portuguese version of EQ-5D]. Acta Med. Port. 26(6), 664\u2013675 (2013).","journal-title":"Acta Med. Port."},{"key":"BFsrep32267_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"Z Nasreddine","year":"2005","unstructured":"Nasreddine Z. et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. American Geriatrics Society. 53(4), 695\u2013699 (2005).","journal-title":"American Geriatrics Society."},{"key":"BFsrep32267_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/13803395.2011.589374","volume":"33","author":"S Freitas","year":"2011","unstructured":"Freitas S., Sim\u00f5es M. R., Alves L. & Santana I. Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population. J. Clin. Exp. Neuropsychol. 33(9), 989\u2013996 (2011).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"BFsrep32267_CR35","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K. et al. The REM sleep behavior disorder screening questionnaired: a new diagnostic instrument. Mov. Disord. 22(16), 2386\u20132393 (2007).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","volume":"12","author":"T Nomura","year":"2011","unstructured":"Nomura T. et al. Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients. Sleep Med. 12(7), 711\u2013713 (2011).","journal-title":"Sleep Med."},{"key":"BFsrep32267_CR37","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B. et al. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov. Disord. 22, 2314\u20132324 (2007).","journal-title":"Mov. Disord."},{"key":"BFsrep32267_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond A. S. & Snaith R. P. The Hospital Anxiety and Depression Scale. Acta Psychiat. Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiat. Scand."},{"key":"BFsrep32267_CR39","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/sleep\/26.8.1049","volume":"26","author":"J Marinus","year":"2003","unstructured":"Marinus, J., Visser, M., van Hilten, J. J., Lammers, G. J. & Stiggelbout, A. M. Assessment of sleep and sleepiness in Parkinson\u2019s disease. Sleep 26, 1049\u20131054 (2003).","journal-title":"Sleep"},{"key":"BFsrep32267_CR40","doi-asserted-by":"crossref","unstructured":"Brandstaedter, D., Spieker, S., Ulm, G. et al. Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson\u2019s disease. J. Neurol. 252(9) (2005).","DOI":"10.1007\/s00415-005-0816-x"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T22:40:02Z","timestamp":1672872002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,10,17]]}},"alternative-id":["BFsrep32267"],"URL":"https:\/\/doi.org\/10.1038\/srep32267","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]},"assertion":[{"value":"24 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32267"}}